アカデミアによる臓器横断的ながん治療情報サイト

学会速報レポート

海外学会で発表されたホットでタイムリーな演題を専門医が厳選。レポートとコメントを掲載しています。

2019 Annual Meeting of the American Society of Clinical Oncology

2019年5月31日~6月4日にシカゴで開催された、2019 Annual Meeting of the American Society of Clinical Oncology®より、消化器癌を中心とした注目演題のレポートを掲載しています。
※取り上げる演題は予告なく変更される場合がございますので、予めご了承ください。

Abstract 4010 食道癌

Abstract 4010:
Pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer: Phase 3 KEYNOTE-181 study.
First Author: Shah MA, et al.

Abstract LBA4007 胃癌

Abstract LBA4007:
Pembrolizumab with or without chemotherapy versus chemotherapy for advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The phase III KEYNOTE-062 study.
First Author: Tabernero J, et al.

Abstract #2522 胃癌大腸癌

Abstract #2522:
Regorafenib plus nivolumab in patients with advanced gastric (GC) or colorectal cancer (CRC): An open-label, dose-finding, and dose-expansion phase 1b trial (REGONIVO, EPOC1603).

Abstract #3501 大腸癌

Abstract #3501:
Prospective pooled analysis of four randomized trials investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months {m}) for patients (pts) with high-risk stage II colorectal cancer (CC).

Abstract 4002 肝胆膵癌

Abstract4002:
A multicenter randomized controlled trial to evaluate the efficacy of surgery vs. radiofrequency ablation for small hepatocellular carcinoma (SURF trial).
First Author: I Namiki, et al.

Abstract LBA 肝胆膵癌

Abstract LBA:
Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial.
First Author: Kindler, H L,, et al.